JP2009518410A5 - - Google Patents

Download PDF

Info

Publication number
JP2009518410A5
JP2009518410A5 JP2008544428A JP2008544428A JP2009518410A5 JP 2009518410 A5 JP2009518410 A5 JP 2009518410A5 JP 2008544428 A JP2008544428 A JP 2008544428A JP 2008544428 A JP2008544428 A JP 2008544428A JP 2009518410 A5 JP2009518410 A5 JP 2009518410A5
Authority
JP
Japan
Prior art keywords
dsrna
medicament according
vaccine
animal
avian influenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008544428A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009518410A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/046356 external-priority patent/WO2007067517A2/en
Publication of JP2009518410A publication Critical patent/JP2009518410A/ja
Publication of JP2009518410A5 publication Critical patent/JP2009518410A5/ja
Pending legal-status Critical Current

Links

JP2008544428A 2005-12-07 2006-12-06 インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのｄｓＲＮＡ Pending JP2009518410A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74290605P 2005-12-07 2005-12-07
US75289805P 2005-12-23 2005-12-23
US79323906P 2006-04-20 2006-04-20
PCT/US2006/046356 WO2007067517A2 (en) 2005-12-07 2006-12-06 Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013013055A Division JP2013075920A (ja) 2005-12-07 2013-01-28 インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのｄｓＲＮＡ

Publications (2)

Publication Number Publication Date
JP2009518410A JP2009518410A (ja) 2009-05-07
JP2009518410A5 true JP2009518410A5 (https=) 2010-02-25

Family

ID=38123418

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008544428A Pending JP2009518410A (ja) 2005-12-07 2006-12-06 インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのｄｓＲＮＡ
JP2013013055A Pending JP2013075920A (ja) 2005-12-07 2013-01-28 インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのｄｓＲＮＡ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013013055A Pending JP2013075920A (ja) 2005-12-07 2013-01-28 インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのｄｓＲＮＡ

Country Status (6)

Country Link
US (3) US7943147B2 (https=)
EP (1) EP1957101A4 (https=)
JP (2) JP2009518410A (https=)
AU (1) AU2006322073A1 (https=)
CA (1) CA2632516C (https=)
WO (1) WO2007067517A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005009337A2 (en) * 2003-05-16 2005-02-03 Hemispherx Biopharma Treating severe acute respiratory syndrome
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections
AU2006322073A1 (en) * 2005-12-07 2007-06-14 Hemispherx Biopharma, Inc. dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants
CA2690641A1 (en) * 2007-06-18 2008-12-24 Hemispherx Biopharma, Inc. Early intervention of viral infections with immune activators
CA2700808C (en) 2007-09-27 2017-11-14 Immunovaccine Technologies Inc. Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
JP2011525169A (ja) * 2008-02-15 2011-09-15 へミスフェリックス・バイオファーマ，インコーポレーテッド Ｔｏｌｌ様受容体３の選択的アゴニスト
US20110110979A1 (en) * 2008-04-16 2011-05-12 Universite De Lausanne Method and vaccine for optimizing the specific immune responses
ES2524699T3 (es) * 2008-06-05 2014-12-11 Immunovaccine Technologies Inc. Composiciones que comprenden liposomas, un antígeno, un polinucleótido y un vehículo que comprende una fase continua de una sustancia hidrófoba
ES2588183T3 (es) 2009-03-31 2016-10-31 Japan As Represented By Director-General Of National Institute Of Infectious Diseases Procedimiento para la prevención de la gripe utilizando una vacuna para administración intranasal
JP6240077B2 (ja) 2011-10-06 2017-11-29 イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． Ｔｌｒ２を活性化するか、またはその活性を増加させるアジュバントを含むリポソーム組成物およびその使用
JP2022543735A (ja) 2019-07-02 2022-10-14 エヌエー ヴァクシン インスティテュート 新規のリボ核酸、及びそれを基にする薬剤学的組成物
WO2021040439A1 (ko) * 2019-08-28 2021-03-04 주식회사 엔에이백신연구소 신규한 핵산을 기반으로 하는 인플루엔자 백신 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906092A (en) * 1971-11-26 1975-09-16 Merck & Co Inc Stimulation of antibody response
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
US4349538A (en) * 1979-12-07 1982-09-14 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
US5132292A (en) * 1990-05-25 1992-07-21 Hem Research, Inc. Treatment of viral hepatitis
US6589529B1 (en) * 1998-10-30 2003-07-08 Children's Hospital Medical Center Rotavirus subunit vaccine
GB0119346D0 (en) * 2001-08-08 2001-10-03 Bioclones Proprietary Ltd Process for the maturation of dendritic cells
RU2390351C2 (ru) 2003-08-11 2010-05-27 Дзе Ресерч Фаундейшн Фо Макробайал Дизизес Оф Осака Юниверсити Вакцина против вируса гриппа для введения через слизистую и способ предотвращения гриппа
US7834064B2 (en) * 2005-01-03 2010-11-16 Andres Mario Salazar Clinical method for the immunomodulatory and vaccine adjuvant use of poly-ICLC and other dsRNAs
AU2006322073A1 (en) * 2005-12-07 2007-06-14 Hemispherx Biopharma, Inc. dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants
EP2134172A4 (en) 2007-03-05 2011-06-01 Univ Utah State RESTRICTIVE AGONIST OF THE TOLL LIKE RECEPTOR 3

Similar Documents

Publication Publication Date Title
JP6378380B2 (ja) ワクチン組成物
CY1122291T1 (el) Αναστολeις ιικου αναδιπλασιασμου
JP2009518410A5 (https=)
JP2013516450A5 (https=)
JP2009511084A5 (https=)
JP2009539965A5 (https=)
Hayden Advances in antivirals for non‐influenza respiratory virus infections
JP2011504486A5 (https=)
CN113304166B (zh) 核苷类化合物在制备治疗冠状病毒感染性疾病的药物中的用途
Cai et al. 14-Deoxy-11, 12-didehydroandrographolide attenuates excessive inflammatory responses and protects mice lethally challenged with highly pathogenic A (H5N1) influenza viruses
Gasparini et al. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza Part II: Future compounds against influenza virus
JP2013518107A5 (https=)
JP2013126989A5 (https=)
FI3300743T3 (fi) Menetelmiä rokotteen antamiseksi
Budimir et al. Heterosubtypic cross‐protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration
JP2017524682A5 (https=)
JP2010270130A5 (https=)
CN101744805B (zh) 穗花杉双黄酮作为唯一活性成分在制备治疗乙肝病毒药物中的应用
JP2019510064A5 (https=)
Kitano et al. Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques
JP2016520077A5 (https=)
Zheng et al. In vitro screening of traditional Chinese medicines compounds derived with anti-encephalomyocarditis virus activities
JP2009518410A (ja) インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのｄｓＲＮＡ
JP2010528053A (ja) インフルエンザ感染症を治療するための物質および方法
JP2014512353A5 (https=)